Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2003
04/22/2003US6551822 NL4 tie ligand homologue
04/22/2003US6551812 Diagnosing PPAR pathophysiologies, and identifying agents for treating these pathophysiologies, using nucleic acids whose expression changes following addition to cells of a ligand for PPAR
04/22/2003US6551811 Protein comprises at least one site for N-linked glycosylation and is attached to a plasma membrane by a glycosylphosphatidylinositol radical
04/22/2003US6551810 Polypeptide retains the ability to dephosphorylate an activated MAP-kinase
04/22/2003US6551808 Desaturase antigen of Mycobacterium tuberculosis
04/22/2003US6551794 Includes a protectant selected from a specified zwitterionic amino acid(s), trehalose, glycerol and ammonium sulphate, a buffer, and water soluble bulking agents; making fibrin; stabilized thrombin-like enzyme; sterility
04/22/2003US6551791 Rapid diagnostic method for distinguishing allergies and infections and nasal secretion collection unit
04/22/2003US6551790 Detecting prefrential metabolite formation; obtain sample, incubate with substrate and enzyme, monitor generation of preferential metabolites
04/22/2003US6551789 Process for characterizing a biological sample using patterns of oncogene expression
04/22/2003US6551788 Particle-based ligand assay with extended dynamic range
04/22/2003US6551786 Screen assay for selecting protein-protein interaction modulators
04/22/2003US6551783 Using a polymerase chain reaction (PCR) based assay in which amplification of nucleic acid is detected by release of a reporter fluorescent signal which is measured as a nomialized reporter value "deltaRn"
04/22/2003US6551775 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1
04/22/2003US6551773 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
04/22/2003US6551772 Model for viral infection and immune response
04/22/2003US6551599 Monoclonal antibodies against campylobacter jejuni and campylobacter coli outer membrane antigens
04/22/2003US6551597 Vaccine compositions for human papillomavirus
04/22/2003US6551594 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
04/22/2003US6551593 Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam
04/22/2003US6551575 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity
04/22/2003US6551554 For counting spermatozoa without use of photoresist
04/22/2003US6551495 Electrochemical assays
04/22/2003US6551494 Non-leachable redox mediator, an air-oxidizable redox mediator, immobilized on a working electrode; determining concentration of glucose in blood
04/22/2003US6551451 Method for determining liquid content in chemical pulps using ramen spectrometry
04/22/2003US6551019 Device for checking the compaction for vibration compaction devices
04/22/2003US6550310 Catalytic adsorption and oxidation based carbon monoxide sensor and detection method
04/22/2003US6550304 Method of compensating a MOS gas sensor, method of manufacturing a MOS gas sensor, MOS gas sensor, and fuel cell system
04/22/2003CA2295769C Moisture sensor for ore concentrates and other particulate materials
04/22/2003CA2189587C Glass/cellulose as protein reagent
04/22/2003CA2170757C Method of marking eukaryotic cells by the use of a cell surface receptor as a marker
04/22/2003CA2137793C Crystallization of m-csf
04/22/2003CA2114327C Haptens, tracers, immunogens and antibodies for immunoassays for propoxyphene
04/22/2003CA2098295C G protein-coupled glutamate receptors
04/22/2003CA2096975C Cell stress transcriptional factors
04/22/2003CA2088368C Assay technique
04/22/2003CA2054602C Method for assaying for a substance that affects an sh2-phosphorylated ligand regulatory system
04/22/2003CA2043862C Assay for cobalamins
04/22/2003CA2022436C 7-hydroxy coumarins having substitutions in the 4 position
04/22/2003CA1341427C Variants of immunoglobulin gene superfamily member
04/19/2003CA2408762A1 Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies
04/19/2003CA2408462A1 Flow thru reaction chamber for sensor chips
04/17/2003WO2003032558A2 METHOD AND A SYSTEM FOR AUTOMATING THE EXECUTION OF AMoRe OVER A HETEROGENOUS NETWORK OF COMPUTERS
04/17/2003WO2003032411A2 Electrochemical cell
04/17/2003WO2003032291A2 Method and device for performing automated, industrial analysis and/or classification of foodstuffs, and foodstuffs
04/17/2003WO2003032234A1 Blood and tissue sample assessment of mitochondrial function and biochemistry as a tool for selection for feed efficiency and other production parameters
04/17/2003WO2003032138A2 Device having touch sensitivity functionality
04/17/2003WO2003032108A2 Confirmation sequencing
04/17/2003WO2003031987A2 In vitro model for priocidal activity
04/17/2003WO2003031986A2 Application of the crystal structure of nusa in drug discovery
04/17/2003WO2003031985A2 Method for identification of modulators of pre-adipocyte differentiation
04/17/2003WO2003031984A2 Method for analysing the sequence of polypeptides
04/17/2003WO2003031983A2 Method for detecting amino acids
04/17/2003WO2003031982A1 Method for analysing protein/peptide expression
04/17/2003WO2003031981A2 Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
04/17/2003WO2003031980A1 System and apparatus for use in detecting microorganisms
04/17/2003WO2003031979A1 Randomly ordered arrays and methods of making and using
04/17/2003WO2003031978A1 Medium for isolating, detecting, separating, or purifying chemical and biological subtances
04/17/2003WO2003031977A2 Binding assay using a magnetic field
04/17/2003WO2003031976A2 Calibrating microarrays
04/17/2003WO2003031975A1 Homogeneous ligand binding assay
04/17/2003WO2003031974A1 Luminescent polymer and use thereof in bioassay
04/17/2003WO2003031973A1 Ldl receptor signaling assays
04/17/2003WO2003031971A1 Reagent for detecting risk factor for alzheimer's disease, detection kit therefor and method of detecting risk factor for alzheimer's disease using the same
04/17/2003WO2003031970A2 Method and apparatus for diagnosing hemostasis
04/17/2003WO2003031969A1 Novel method of assaying immune activity
04/17/2003WO2003031968A1 Device and method for measuring and/or detecting a gas level and flow in the breath
04/17/2003WO2003031967A1 Kits for diagnosing kidney diseases
04/17/2003WO2003031963A1 Soil probe insertion arrangement and method of use
04/17/2003WO2003031952A1 Luminescence detecting device and luminescence detecting microarray plate
04/17/2003WO2003031947A2 Device for sequencing nucleic acid molecules
04/17/2003WO2003031945A1 Concentration measurement by sensing hydrogel pressure
04/17/2003WO2003031942A1 Reagents and methods useful for detecting diseases of the breast
04/17/2003WO2003031940A2 Structural and cytoskeleton-associated proteins
04/17/2003WO2003031939A2 Protein modification and maintenance molecules
04/17/2003WO2003031936A2 System, method, and apparatus for submitting genetic samples and receiving genetic testing results anonymously
04/17/2003WO2003031935A2 System, method, and apparatus for disease susceptibility testing
04/17/2003WO2003031934A2 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis b viral dna
04/17/2003WO2003031932A2 Methods and compositions for detecting colon cancers
04/17/2003WO2003031930A2 A phosphatase associated with metastasis
04/17/2003WO2003031928A2 Cellular engineering, protein expression profiling, differential labeling of peptides, and novel reagents therefor
04/17/2003WO2003031904A2 Non-contact sheet sensing system and related method
04/17/2003WO2003031699A1 Method and test device for testing fibrous material in terms of the characteristic values thereof
04/17/2003WO2003031620A1 Novel class ii cytokine receptor
04/17/2003WO2003031604A1 Gastrointestinal chemosensory receptors
04/17/2003WO2003031600A1 Saccharomyces-cerevisiae yeast strain with stable integration and expression of the nucleic acid sequence for a heterologous potassium ion channel
04/17/2003WO2003031595A2 Molecules for disease detection and treatment
04/17/2003WO2003031584A2 Axon repair
04/17/2003WO2003031578A2 Mammalian c-type lectins
04/17/2003WO2003031577A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
04/17/2003WO2003031573A2 Toll-like receptor 3 signaling agonists and antagonists
04/17/2003WO2003031571A2 Novel human proteins, polynucleotides encoding them and methods of using the same
04/17/2003WO2003031568A2 Intracellular signaling molecules
04/17/2003WO2003031567A2 Precursor conversion screening methods
04/17/2003WO2003031565A2 Integrated system and method for analysis of genomic sequence data
04/17/2003WO2003031563A1 Sensors for the detection of an analyte
04/17/2003WO2003031562A1 Portable biosensor apparatus with controlled flow
04/17/2003WO2003031468A1 Therapeutic and diagnostic molecules that are capable of interacting with socs proteins
04/17/2003WO2003031463A2 14081, a human trypsin-like serine protease family member and uses therefor
04/17/2003WO2003031462A2 Nogo receptor-mediated blockade of axonal growth
04/17/2003WO2003031448A1 Reverse-turn mimetics and method relating thereto